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Abstract
The intake of marine n-3 PUFA has been shown to decrease the risk of CVD in a number of studies. Since the development of CVD is often
a lifelong process, marine n-3 PUFA intake early in life may also affect the development of later CVD. The aim of the present study was to
investigate the association between maternal intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated
with cardiometabolic risk in the 20-year-old offspring. The study was based on the follow-up of the offspring of a Danish pregnancy cohort
who participated in a study conducted from 1988 to 1989. A total of 965 pregnant women were originally included in the cohort and
detailed information about the intake of marine n-3 PUFA during the second trimester was collected. In 2008–9, the offspring were invited
to participate in a clinical examination including anthropometric, blood pressure (BP) and short-term heart rate variability measurements.
Also, a fasting venous blood sample was drawn from them. Multiple linear regression modelling, using the lowest quintile of marine n-3
PUFA intake as the reference, was used to estimate the association with all outcomes. A total of 443 offspring participated in the clinical
examination. No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and offspring adiposity,
glucose metabolism, BP or lipid profile was found. In conclusion, no association between the intake of marine n-3 PUFA during the
second trimester of pregnancy and the factors associated with cardiometabolic risk in the 20-year-old offspring could be detected.
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Nutritional influences on the development of CVD may
operate throughout life(1–3). During fetal life, marine n-3 PUFA,
mainly found in fatty fish, are transferred to the fetus from the
mother(4). The fact that marine n-3 PUFA are incorporated into
cell membranes(5) and are involved in hormonal pathways(6,7)
and have effects on the expression of genes involved in inflam-
mation and lipid metabolism(8–10) and on the proliferation and
differentiation of adipose tissue(11–13) suggests that dietary
long-chain n-3 PUFA could have an impact on cardiometabolic
risk factors through several mechanisms.
Previous human trials that have investigated the effect of
supplementation with long-chain n-3 PUFA during pregnancy
on factors associated with cardiometabolic risk in offspring
vary in terms of both the intervention period and the
amount of n-3 PUFA given(14–19). Also, the follow-up period
in most of the studies is relatively short. We have recently
followed up the offspring of women who had participated
in a randomised controlled trial with fish oil supplementation
during the third trimester of pregnancy(17–19). The offspring
were followed up after 19 years, and we found no effect of
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fish oil supplementation on any of the measured factors
associated with cardiometabolic risk. However, particularly
the development of adipose tissue already starts in the
second trimester of pregnancy(20), and therefore it is possible
that the intake of marine n-3 PUFA during this period could
influence later adiposity.
Previous studies that have investigated the intake of marine
n-3 PUFA as early as the second trimester of pregnancy have
reported inconsistent results(14–16,21). Hence, the evidence
for a possible programming effect of marine n-3 PUFA
intake during mid-pregnancy on later cardiometabolic risk in
humans is still sparse and inconclusive.
In the present study, we investigated the hypothesis that the
intake of long-chain n-3 PUFA during the second trimester of
pregnancy has an impact on factors associated with cardiome-
tabolic risk in the offspring at the age of 19–20 years. Thus,
the offspring from a birth cohort study conducted in 1988–9
were followed up after 20 years.
Methods
Original study
Details about the recruitment and dietary assessments have
been described in detail previously(22).
In brief, the original study population included 965 pregnant
women recruited for a birth cohort study in Aarhus,
Denmark, from April 1988 until January 1989. These women rep-
resented 80% of a consecutive sample of 1212 women making
visits for routine antenatal care to a specific midwife centre in
the city. The women filled out a self-administered dietary ques-
tionnaire 1 week before the scheduled antenatal visit in week
30 of gestation, and provided that consent was given, a sup-
plementary face-to-face interview was conducted after the visit.
A blood samplewasobtained from thewomenafter the interview.
The mean age of the participating women was 29 years; approxi-
mately 58% were nulliparous and 40% had been smoking during
pregnancy. Approximately 9% ate no fish during pregnancy.
Intake of marine n-3 PUFA
The intake of marine n-3 PUFA was quantified by a combi-
nation of the answers given by the women in response to
the self-administered questionnaire and the face-to-face inter-
view. The questionnaire mainly covered breakfast and lunch.
The interview focused on quantifying the main ingredients of
cooked meals and on completing the information
collected from the questionnaire in order to make a quantitat-
ive estimation of the selected food items. Photographs
modelling portion sizes were used in the quantification pro-
cedure. Emphasis was mainly placed on the intake of
marine n-3 PUFA and energy-containing ingredients. Both in
the mailed questionnaire and in the structured interview, the
women were asked to ensure that the reported intakes
represented those taken by them in the recent 3 months, approxi-
mately corresponding to the second trimester of pregnancy. In
the structured interview, a trained person checked and corrected
the questionnaire for any possible misunderstandings.
The estimated contents of marine n-3 PUFA in various food
items used to quantify the total intake of marine n-3 PUFA
have been described previously(22).
A random sample (14 %) of the participating women had
their blood samples analysed with regard to the fatty acid
profile of erythrocytes. The reported daily intake of marine
n-3 PUFA was found to be correlated with the sum of
marine n-3 PUFA in erythrocytes with a correlation coefficient
of 0·45(22).
Follow-up
The offspring of the observational birth cohort constituted the
study population in the present study. At the time of the study,
the offspring were aged between 19 and 20 years. A total of
915 (95 %) mother and child pairs could be identified in the
central registration registry and were alive and living in
Denmark at the time of the follow-up.
The mothers were contacted by mail and informed about
the follow-up. Thereafter, the offspring were contacted and
asked to complete a self-administered Web-based question-
naire concerning their anthropometric measures, health and
lifestyle. They were also asked whether they were interested
in participating in a clinical examination. Those who agreed
and those who did not answer the questionnaire were all
invited to participate in a physical examination. A total of
688 (71 %) filled out the questionnaire and 443 (46 %) partici-
pated in the clinical examination.
The physical examination was performed by a trained nurse
and a trained medical laboratory technician. Height, weight and
waist circumference were measured. Following this, the partici-
pants rested for 5 min and their short-term (2 min) heart rate
(HR) variability (HRV) was measured in a horizontal position
using a validated handheld device (HealthMate; Medicus Engin-
eering)(23,24). HRV was included as a measure of the balance
between sympathetic and parasympathetic activities on the
sinus node. The standard deviation of the time intervals
between consecutive heart beats was determined. While still
in the horizontal position, resting blood pressure (BP) and HR
were measured three times (at an interval of 2 min) with an auto-
matic BP device (OMRON M6 Comfort (HEM-7000-E)). The
mean of the last two measurements was used in the analyses.
Finally, as a measure of the parasympathetic nervous function,
the mean ratio between the highest and the lowest HR within a
breathing cycle (HRVE/I) was measured with the participant sit-
ting at a desk, holding the HealthMate in both hands. The
participant was instructed to breathe slowly for 1 min according
to an illustration on the HealthMate display.
Blood analyses
A fasting (10 h) blood sample was drawn, centrifuged and
frozen at 2808C. Blood glucose was measured using bedside
equipment (Accu-chek; Roche Diagnostics) immediately after
blood sampling.
High-sensitivity C-reactive protein was measured by an immu-
noturbidimetric assay (Randox Laboratories Limited) on an
Advia 1650 (Bayer Diagnostics). Detection limit was 0·20 mg/l.
D. Rytter et al.2038
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HbA1c was measured by an HPLC assay (Bio-Rad
Laboratories) on a Variant II Turbo.
Serum adiponectin, leptin and IgF-1 were determined at
the Medical Research Laboratories in Aarhus, Denmark, by
in-house validated assays. Adiponectin was measured by a
time-resolved immunofluorometric assay based on two anti-
bodies and recombinant human adiponectin (R&D Systems)
as described previously(25). Serum leptin was determined by
a time-resolved immunofluorometric assay based on commer-
cially available reagents (R&D Systems) and recombinant
human leptin as the standard, and carried out essentially as
had been done for adiponectin(25). Serum total IgF-I was
measured by RIA(26). Plasma insulin concentrations were
determined using a commercial ELISA kit (DAKO).
Insulin resistance was estimated using homeostatic model
assessment (HOMA-IR). HOMA-IR was calculated as follows:
HOMA-IR ¼ fasting insulin ðmU=mlÞ
£ fasting glucose ðmmol=lÞ=22·5:
Serum TAG and cholesterol (total, LDL and HDL) were
measured according to standard methods on a Modular P
(Roche Diagnostics). ApoA1 and apoB were measured using
antibodies obtained from DAKO, on an Advia 1650 from
Bayer Diagnostics.
The study was conducted according to the guidelines given
in the Declaration of Helsinki, and all procedures involving
human subjects were approved by the local ethics committee
(journal no. 20070157) and the Danish Data Protection Agency
(journal no. 2006-41–6257). Written informed consent was
obtained from all participants.
Statistical analyses
All statistical tests were performed using STATA software
package 11.0 (Stata Corporation).
A two-sided P value below 0·05 was considered as statisti-
cally significant.
Exposure
As maternal energy intake is a potential confounding factor
when examining the attributes of metabolic disorders in the
offspring, the intake of marine n-3 PUFA was adjusted for
total energy intake using the residual method(27). Following
this, exposure was divided into quintiles. This was done for
the entire study population, regardless of their participation
in the follow-up.
Covariates
x 2 Tests and Student’s t tests were used to compare
categorical and normally distributed continuous variables,
respectively, between the participants and non-participants.
It was a priori decided to adjust for major risk factors for
the outcome. Hence, maternal pre-pregnancy BMI (continu-
ous, 5 % missing), maternal education (elementary school,
high-school or technical school, university, higher academic
or other, 7 % missing) and smoking during pregnancy
(never, ,10 and $10 cigarettes/d, 5 % missing) were included
in the model to adjust for potential genetic and/or environ-
mental disposition to the outcomes. Also, maternal age
(continuous, no missing) and parity (0, 1 or $2, 1 % missing)
were included to adjust for factors associated with the diet
and other factors that could indirectly affect growth and
adiposity. Energy intake was included in the model (quintiles,
1 % missing), since it may have an important association
with the outcomes independent of marine n-3 PUFA. Differen-
tial programming effects of marine n-3 PUFA had been
described previously in males and females, and therefore all
analyses were initially stratified by sex. However, since no
sex-specific effects were found, sex was included in the
model as a potential confounder (no missing). Only partici-
pants with complete information on covariates were included
in the main analyses.
Analyses
Multiple linear regression modelling, using the lowest quintile
of marine n-3 PUFA intake as the reference, was used to
estimate the association with all outcomes.
A total of 16 % of the participants had an high-sensitivity
C-reactive protein value below the detection limit of
0·20 mg/l. Assuming that the data below the detection limit
were missing at random, multiple imputations were used to
impute the values below the detection limit on the basis of
sex, BMI, smoking habit and parental overweight.
The distributions of the biochemical and HRV variables
were generally skewed and therefore log-transformed for nor-
malisation. Following this, all regressions were found to fulfil
the assumptions of normally distributed residuals and approxi-
mately equal variance of residuals.
Due to the relatively high loss to follow-up and an associ-
ation between participation in the clinical examination and
self-reported BMI, a sensitivity analysis was performed in
order to investigate whether the results obtained for BMI
were biased. The correlation between self-reported and clini-
cally measured BMI for the two sexes was used to calculate
and impute BMI values for those who filled out the question-
naire but did not participate in the clinical examination. For
those who did not fill out the questionnaire or participate in
the clinical examination, a value of 25 kg/m2 was imputed. A
BMI of 25 kg/m2 was chosen, since this is a relatively high
and still not totally an unrealistic guess.
Results
The participants and non-participants of the clinical
examination were similar with respect to most of the known
characteristics, such as parity, pre-pregnancy BMI, maternal
age, offspring smoking and exercise habits and parental
overweight. However, the participants were more likely to
be females (60 v. 36 % among non-participants), have a
slightly lower self-reported BMI (21·8 v. 22·5 kg/m2), eat
more fish (42 v. 37 % ate fish as a warm meal at least three
times per month) and to be born to mothers with a higher
n-3 PUFA and offspring cardiometabolic risk 2039
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Table 1. Characteristics of the participants according to the intake of marine n-3 PUFA during the second trimester of pregnancy
(Mean values, standard deviations and percentages)
First quintile (n 84) Second quintile (n 93) Third quintile (n 72) Fourth quintile (n 96) Fifth quintile (n 94)
n Mean SD % Mean SD % Mean SD % Mean SD % Mean SD %
Mother*
Energy-adjusted intake of marine n-3 PUFA (g/d)† 439 0·05 0·02 0·13 0·02 0·21 0·03 0·33 0·04 0·68 0·35
Parity 439
0 52 55 67 61 65
1 36 35 26 27 26
$ 2 12 10 7 11 10
Age while giving birth (years) 439 29·2 3·9 28·9 3·8 28·9 4·1 29·9 4·2 29·0 4·3
Smoking (cigarettes/d) 420
0 67 66 69 71 67
# 10 24 21 17 20 29
. 10 9 13 14 9 4
Pre-pregnancy BMI (kg/m2) 423 21·7 3·2 20·8 2·1 21·3 2·7 21·6 3·7 21·7 3·0
Total energy intake (kJ/d) 439 8751 3306 8856 2045 8846 2580 8566 2036 8367 1973
Education 411
Elementary school 15 8 13 8 6
High school or technical school 22 29 21 21 18
University 36 34 41 47 43
Higher academic 17 15 19 18 27
Other 11 14 6 6 7
Offspring‡
Sex (male) 439 40 43 36 39 40
Smoking 426
Current 19 14 12 17 25
Ex 2 6 3 5 4
Occasional 20 27 33 24 24
Never 58 52 52 53 47
Fish hot meal (per month) 422
Never 15 10 11 7 3
1–2 59 48 44 43 52
3–4 23 29 34 34 26
. 5 4 14 10 16 20
Fish cold meal (per month) 417
Never 27 17 17 16 13
1–2 34 30 44 36 39
3–4 15 28 19 21 18
. 5 24 24 20 26 29
Exercise (yes) 428 74 76 70 72 77
Strenuous exercise§ 412 61 68 55 66 67
Parental overweightk 410 39 32 29 43 42
Self-reported BMI (kg/m2) 414 22·0 2·7 21·6 2·6 21·0 2·5 21·9 3·1 22·2 2·9
Birth weight (g) 438 3462 514 3530 545 3423 495 3496 409 3628 565
Gestational age (d) 420 282 11 284 10 282 14 283 10 282 11
* Information collected from the self-administered questionnaire and structured interview of pregnant women in week 30 of gestation. Additional data collected from birth records.
† The intake of marine n-3 PUFA during the second trimester of pregnancy adjusted for daily energy intake by the residual method.
‡ Information collected from a self-administered Web-based questionnaire filled up by the offspring at the age of 19 years. Sex, birth weight and gestational age collected from birth records.
§ Defined as exercise of at least 20 min duration, resulting in breathlessness.
kThe participants were asked as to whether they would consider any of their parents to be overweight.
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education (59·7 v. 47·1 % had a university or higher academic
education) who were smoking less during pregnancy com-
pared with the non-participants (37 v. 43 %). The participants
and non-participants did not differ with regard to maternal
intake of marine n-3 PUFA during the second trimester of
pregnancy. Information about maternal intake of marine n-3
PUFA during pregnancy was lacking for four participants,
leaving 439 participants available for analysis.
When comparing participant characteristics across quintiles
of energy-adjusted n-3 PUFA intake, the groups only differed
significantly with regard to offspring fish intake (Table 1).
Thus, offspring intake of fish increased with maternal intake
of marine n-3 PUFA during pregnancy. The proportion with a
university education or an academic education tended to be
higher in the highest fish intake quintile compared with the
lowest one (43 plus 27 % v. 36 plus 17 %), as was observed for
primiparous women compared with multiparous one (65 v.
52 %). Otherwise, the groups were similar with regard to the
known characteristics.
BMI, waist circumference and related biochemical
characteristics
The mean BMI was 22·8 and 22·1 kg/m2 in males and
females, respectively, and the prevalence of overweight
(BMI $25 kg/m2) was 20 % among males and 16 % among
females. The mean waist circumference was 83 cm in males and
80 cm in females.
There was no association between the intake of marine n-3
PUFA during pregnancy and BMI or waist circumference in the
offspring (Table 2). Sensitivity analysis for BMI did not change
the estimated differences substantially. Also, overall no statisti-
cally significant association was found between the intake of
marine n-3 PUFA and glucose metabolism, evaluated by fast-
ing glucose, insulin, HOMA and HbA1c in the offspring
(Table 3). Furthermore, the adipose tissue-derived hormones
leptin and adiponectin as well as high-sensitivity C-reactive
protein and IgF-1 were not associated with the intake of
marine n-3 PUFA during pregnancy.
Blood pressure, heart rate and heart rate variability
The mean systolic BP and diastolic BP in males were 118 and
64mmHg, respectively. A total of 35% had a systolic BP above
120mmHg, whereas only 2% had a diastolic BP above 80mmHg.
In females, the mean systolic BP was 105 mmHg and
diastolic BP was 66 mmHg. The prevalence of women with a
systolic BP above 120 mmHg and a diastolic BP above
80 mmHg was 3 and 1 %, respectively.
Maternal intake of marine n-3 PUFA during pregnancy
was non-significantly associated with offspring BP, HR and
HRV (Table 4).
Lipid profile
Of the entire study population, 19 % had total cholesterol
above 5 mmol/l, 8 % had an HDL-cholesterol concentration
below 1·03 mmol/L, 19 % had an LDL-cholesterol concen-
tration above 3 mmol/l and 3 % had a TAG concentration
above 2 mmol/l.
The overall intake of marine n-3 PUFA during the second
trimester of pregnancy was not associated with cholesterol
(HDL, LDL and total), apoA1 and apoB or TAG concentration
in the offspring (Table 5). However, the concentration of TAG
was statistically significantly higher in the fourth quintile
compared with that in the lowest quintile of marine n-3
PUFA intake.
Discussion
We found no association between the intake of marine n-3
PUFA in the second trimester of pregnancy and several cardi-
ometabolic risk factors in the 19–20-year-old offspring. Thus,
no association was found with BMI and waist circumference,
glucose metabolism, adipose tissue-derived hormones, BP,
HR, HRV or lipid profile. The only difference reaching statisti-
cal significance was the higher TAG concentration in the
fourth quintile compared with the lowest quintile of marine
n-3 PUFA intake. However, no general trend towards an
association between the intake of marine n-3 PUFA and TAG
Table 2. Association between quintiles (Q) of energy-adjusted intake of marine n-3 PUFA
during the second trimester of pregnancy and offspring adiposity
(Mean values and standard deviations; adjusted differences and 95 % confidence intervals)
Quintiles of energy-adjusted
marine n-3 PUFA Mean (n 439) SD
Adjusted difference
(n 395)* 95 % CI
BMI (kg/m2)
Q1 22·72 3·11 Reference –
Q2 22·11 2·94 20·53 21·49, 0·42
Q3 21·68 3·12 21·01 22·03, 0·01
Q4 22·52 3·15 20·31 21·27, 0·64
Q5 22·88 3·43 20·02 20·99, 0·94
P for trend 0·821
Waist (cm)
Q1 82·04 8·96 Reference 2
Q2 80·92 8·04 21·16 23·75, 1·44
Q3 79·25 8·20 22·43 25·20, 0·35
Q4 81·99 9·32 20·19 22·78, 2·39
Q5 81·73 9·03 20·71 23·33, 1·91
P for trend 0·923
* Adjusted for maternal pre-pregnancy BMI, maternal education, smoking during pregnancy, maternal age,
parity, energy intake and sex.
n-3 PUFA and offspring cardiometabolic risk 2041
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was found, and since a lot of comparisons have been made,
this may be a chance finding.
The relatively high loss to follow-up could potentially have
led to a bias of the estimates. A description of the participants
and non-participants has been published previously(28). Self-
reported BMI was higher among the non-participating females
compared with the participating ones in the clinical examin-
ation. Also, we did not have any information about BMI for
Table 3. Association between quintiles (Q) of energy-adjusted intake of marine n-3 PUFA during the second
trimester of pregnancy and markers of cardiometabolic risk in the offspring
(Medians and interquartile ranges; % adjusted differences and 95 % confidence intervals)
Quintiles of energy-adjusted
marine n-3 PUFA Median Interquartile range
% Adjusted
difference* 95 % CI
Glucose (mmol/l)
Q1 4·9 4·6–5·3 Reference –
Q2 4·9 4·7–5·2 2 21, 4
Q3 4·9 4·6–5·3 2 21, 5
Q4 4·9 4·7–5·2 1 22, 4
Q5 4·9 4·6–5·2 1 22, 3
P for trend 0·998
Insulin (pmol/l)
Q1 44 31–55 Reference 2
Q2 42 33–55 4 29, 19
Q3 36 27–47 212 224, 2
Q4 42 30–53 0 212, 15
Q5 36 28–46 29 220, 4
P for trend 0·144
HOMA-IR†
Q1 1·38 0·97–1·68 Reference –
Q2 1·36 0·96–1·80 6 28, 21
Q3 1·15 0·85–1·54 210 222, 5
Q4 1·29 0·98–1·69 1 212, 16
Q5 1·13 0·86–1·44 28 220, 6
P for trend 0·164
HbA1c (%)
Q1 5·2 5·0–5·3 Reference –
Q2 5·2 5·0–5·4 0 21, 2
Q3 5·2 5·0–5·4 21 22, 1
Q4 5·2 5·0–5·4 1 21, 2
Q5 5·2 5·0–5·3 21 23, 1
P for trend 0·316
Leptin (mg/l)
Q1 8·92 2·21–18·60 Reference –
Q2 6·67 2·96–13·55 0 223, 31
Q3 8·06 2·59–12·37 217 237, 10
Q4 8·97 3·87–17·11 21 27, 58
Q5 8·57 3·33–17·01 10 216, 44
P for trend 0·193
Adiponectin (mg/l)
Q1 8·24 6·36–10·26 Reference –
Q2 7·93 6·03–10·56 21 212, 12
Q3 8·67 6·50–11·80 8 25, 23
Q4 8·66 6·41–10·60 2 29, 15
Q5 8·46 6·44–10·53 11 22, 25
P for trend 0·083
hs-CRP (mg/l)
Q1 0·90 0·28–2·57 Reference –
Q2 0·77 0·34–2·10 14 224, 72
Q3 0·67 0·29–1·63 212 243, 37
Q4 0·88 0·35–2·78 26 216, 88
Q5 0·73 0·26–1·98 10 227, 65
P for trend 0·533
IgF-1 (mg/l)
Q1 229 198–273 Reference –
Q2 245 195–300 2 26, 11
Q3 241 214–287 0 28, 10
Q4 248 207–285 3 25, 12
Q5 230 185–268 24 211, 5
P for trend 0·483
HOMA-IR, homeostatic model assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein.
* Adjusted difference in % relative to the lowest quintile of marine n-3 PUFA intake. Adjusted for maternal pre-pregnancy
BMI, maternal education, smoking during pregnancy, maternal age, parity, energy intake and sex.
† HOMA index calculated as follows: fasting insulin (mU/ml)£ fasting glucose (mmol/l)/22·5.
D. Rytter et al.2042
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221 subjects. The prevalence of overweight in the study was
somewhat lower than the estimated one among young
people in Denmark in 2010 (20·5 v. 25·8 % in males and 16·1
v. 20·2 % in females)(29). These data put together could indi-
cate a lower participation among subjects with a high BMI.
Nevertheless, participation was not associated with exposure
in the study, indicating that the possible larger attrition
among subjects with a high BMI would not lead to a bias of
the estimates. To further investigate a possible selection bias,
a sensitivity analysis was performed. Imputing a BMI of
25 kg/m2 for those offspring who were completely lost to
follow-up, and using self-reported BMI to calculate and
impute expected values for those who only filled out the ques-
tionnaire, did not change the estimated difference in BMI
between the exposure groups materially and, if anything,
made the estimated differences even smaller. Participation
per se would not be expected to be directly associated with
BP or lipid profile, since most of the participants were prob-
ably unaware of these values.
Originally, 80 % of eligible pregnant women agreed to par-
ticipate in the study. No information is available for the
remaining 20 %, and it cannot be ruled out that these
women were different from those who agreed to participate.
There is, however, no reason to believe that they should be
different with respect to the association between the intake
of marine n-3 PUFA during the second trimester of pregnancy
and later cardiometabolic risk in the offspring.
The lack of associations in the present study may be due to
a statistical type 2 error. Hence, the study may not have been
large enough to detect small differences in the outcomes. Also,
Table 4. Association between quintiles (Q) of energy-adjusted intake of marine n-3 PUFA during the
second trimester of pregnancy and offspring blood pressure, heart rate (HR) and short-term HR variabil-
ity indices
(Mean values and standard deviations; adjusted differences and 95 % confidence intervals)
Quintiles of energy-adjusted
marine n-3 PUFA Mean SD Adjusted difference 95 % CI
SBP (mmHg)
Q1 110 12 Reference –
Q2 110 10 0 22, 3
Q3 109 11 20 23, 3
Q4 110 10 1 22, 3
Q5 111 10 0 23, 3
P for trend 0·854
DBP (mmHg)
Q1 66 8 Reference –
Q2 64 6 21 23, 1
Q3 66 7 1 22, 3
Q4 66 6 1 22, 3
Q5 66 7 0 22, 2
P for trend 0·484
HR (bpm)
Q1 63 11 Reference –
Q2 61 8 23 26, 0
Q3 63) 11 0 23, 3
Q4 63 11 21 24, 2
Q5 61 9 22 25, 2
P for trend 0·852
Median Interquartile range % Adjusted difference* 95 % CI
SDNN (ms)†
Q1 59 40–81 Reference –
Q2 61 46–73 4 213, 21
Q3 63 44–86 8 29, 28
Q4 67 42–90 12 25, 32
Q5 66 46–88 9 28, 28
P for trend 0·162
HRE/I‡
Q1 1·39 1·30–1·50 Reference –
Q2 1·41 1·33–1·48 0 23, 3
Q3 1·41 1·33–1·50 0 23, 4
Q4 1·44 1·34–1·54 2 22, 5
Q5 1·40 1·30–1·50 21 24, 2
P for trend 0·923
SBP, systolic blood pressure; DBP, diastolic blood pressure; bpm, beats/min; SDNN, standard deviation of the time inter-
vals between consecutive heart beats; HRE/I, median ratio between the highest and the lowest heart rate within every
breathing cycle.
* Difference in % relative to the lowest quintile of marine n-3 PUFA intake during the second trimester of pregnancy.
† SDNN in a 2 min heart rate recording.
‡ HRE/I in a 1 min recording.
n-3 PUFA and offspring cardiometabolic risk 2043
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the exposure contrast may not have been large enough to
cause differences between the groups. However, most of the
estimated differences were small, and the present study is
one of the largest and most comprehensive studies to date
that has examined the association between early intake of
marine n-3 PUFA intake and later cardiometabolic risk.
The intake of marine n-3 PUFA was calculated based on the
self-reported dietary intake of different food items. This infor-
mation could contain some degree of imprecision, making it
difficult to detect differences between the groups. However,
the self-reported dietary intake was shown to be positively
correlated with the sum of marine n-3 PUFA in erythro-
cytes(22). Also, both in the original questionnaire and in the
following interview, emphasis was mainly placed on making
it possible to quantify the intake of marine n-3 PUFA and
more effort was put to get as correct and precise answers as
possible. Hence, we believe that the dietary assessment of
fish intake corresponds relatively well to the actual intakes
during the second trimester of pregnancy. Any potential mis-
classification of the exposure is most probably not associated
with the outcome, but could be the reason for us being unable
to detect differences between the groups.
The observational design of the study also increases the risk
of confounding. We did adjust for a number of potential con-
founders, and most of the important characteristics were
found to be not associated with the exposure. The intake of
fish is generally associated with higher social status and a heal-
thier lifestyle, but assuming the positive effects of marine n-3
PUFA on cardiovascular health, confounding from such factors
does not explain the null findings of the present study.
The evidence from previous studies on the association
between fish intake during pregnancy and later adiposity is
Table 5. Association between quintiles (Q) of energy-adjusted intake of marine n-3 PUFA during the second
trimester of pregnancy and offspring lipid parameters
(Medians and interquartile ranges; % adjusted differences and 95 % confidence intervals)
Quintiles of energy-adjusted
marine n-3 PUFA Median Interquartile range % Adjusted difference† 95 % CI
Total cholesterol
Q1 4·2 3·8–4·9 Reference –
Q2 4·3 3·7–4·8 22 27, 4
Q3 4·2 3·7–4·9 0 26, 6
Q4 4·4 4·0–5·0 4 22, 10
Q5 4·3 3·8–4·8 0 26, 6
P for trend 0·376
HDL-cholesterol
Q1 1·4 1·3–1·7 Reference –
Q2 1·4 1·2–1·7 1 26, 8
Q3 1·4 1·3–1·6 21 28, 6
Q4 1·5 1·2–1·7 2 25, 8
Q5 1·4 1·3–1·7 2 24, 9
P for trend 0·487
LDL-cholesterol
Q1 2·3 2·0–2·9 Reference –
Q2 2·4 1·9–2·8 23 211, 6
Q3 2·3 2·0–2·9 1 28, 11
Q4 2·4 2·1–2·9 3 26, 13
Q5 2·3 2·0–2·9 20 29, 9
P for trend 0·566
TAG
Q1 0·9 0·6–1·1 Reference –
Q2 0·9 0·7–1·3 3 29, 17
Q3 0·8 0·6–1·2 0·1 212, 15
Q4 0·9 0·8–1·3 18* 4, 34
Q5 0·8 0·7–1·2 0 212, 14
P for trend 0·354
ApoA1
Q1 1·5 1·3–1·6 Reference –
Q2 1·4 1·3–1·6 1 24, 6
Q3 1·4 1·3–1·6 21 26, 4
Q4 1·5 1·3–1·7 4 21, 9
Q5 1·5 1·3–1·7 2 23, 7
P for trend 0·310
ApoB
Q1 0·8 0·7–1·0 Reference
Q2 0·8 0·7–1·0 23 210, 4
Q3 0·8 0·7–1·0 20 28, 8
Q4 0·8 0·7–1·0 2 25, 10
Q5 0·8 0·7–0·9 21 28, 6
P for trend 0·748
* Statistically significant difference relative to the lowest quintile.
† Difference in % relative to the lowest quintile of marine n-3 PUFA intake during the second trimester of pregnancy.
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relatively sparse(14–17,21). We have recently followed up a
randomised controlled trial with fish oil supplementation
from the 30th week of gestation, undertaken in the same
population of Aarhus, and found no effects on adiposity in
the 19-year-old offspring(17). In a randomised controlled trial
carried out in Norway also, no association has been reported
between supplementation with marine n-3 PUFA from gesta-
tional week 18 until 3 months after delivery and BMI at the
age of 7 years(14). Likewise, no overall association could be
documented between supplementation with the marine n-3
PUFA DHA from gestational week 20 until delivery and
anthropometry at 18 weeks of age in a large trial with
marine n-3 PUFA supplementation carried out in pregnant
women(16). In contrast, Lucia et al.(15) reported a lower BMI
among 21-month-old children whose mothers had been
randomised to marine n-3 PUFA together with a vitamin and
mineral supplement compared with vitamins and minerals
taken alone. This finding has recently been supported by
results from an observational study reporting an inverse
association between the intake of marine n-3 PUFA during
mid/late pregnancy and the risk of obesity at 3 years of age(21).
Only two studies have previously investigated the associ-
ation between the intake of marine n-3 PUFA during
pregnancy and later offspring BP(19,30). In our 19-year
follow-up of a randomised trial, no effect of supplementation
with marine n-3 PUFA during the third trimester of pregnancy
on offspring BP was found(19). Similarly, the observational
study by Leary et al.(30) reported no association between the
intake of marine n-3 PUFA during late pregnancy and
offspring systolic BP at the age of 7·5 years.
The present study supports the findings on lipid profile
from our previous randomised controlled trial with marine
n-3 PUFA supplementation, where no effect of supplemen-
tation with marine n-3 PUFA could be documented(18).
In conclusion, we found no association between the
intake of marine n-3 PUFA during the second trimester of
pregnancy and cardiometabolic risk in the 19–20-year-old
offspring.
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